查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞和基因治疗市场规模及预测（2021-2031年），全球及区域份额、趋势、成长机会分析报告：按类型、服务、规模、服务供应商、转染试剂、最终用户和地区划分
市场调查报告书
商品编码
1938233

细胞和基因治疗市场规模及预测（2021-2031年），全球及区域份额、趋势、成长机会分析报告：按类型、服务、规模、服务供应商、转染试剂、最终用户和地区划分

Cell and Gene Therapy Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Service, Scale, Service Providers, Transfection Reagents, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 300 Pages | 订单完成后即时交付

价格
细胞和基因治疗市场规模预计将从2024年的53亿美元成长到2031年的257.8亿美元，2025年至2031年的复合年增长率（CAGR）为25.5%。慢性病和遗传性疾病的日益增多、细胞和基因治疗生产外包的快速普及以及监管核准和商业化的激增是推动细胞和基因治疗市场规模扩张的重要因素。此外，下一代基因编辑工具的开发预计将在不久的将来引领细胞和基因治疗的新趋势。

人工智慧和自动化正在对细胞和基因治疗（CGT）领域产生革命性的影响。为了克服当前的挑战，学术界正在利用人工智慧进行预测建模，并结合自动化流程改进来优化规划。史丹佛大学医学院的CRISPR-GPT是一种人工智慧技术，可以自动规划基因编辑相关的实验，将试验的时间从数月缩短到数天。同样，耶鲁大学医学院的生成式人工智慧模型可以设计新型DNA序列，透过开启或关闭基因来开发更安全的基因治疗载体，用于临床前研究。

自动化与人工智慧完美契合，因为它能减少生产过程中的人工干预。在这方面，Cellares公司的Cell Shuttle系统利用机器人技术实现了CAR-T细胞的全自动生产，纯度提升，处理速度提高至多10倍。这些进步带来了显着优势。根据《生物工艺国际》报导，自动化透过提高合规性和柔软性，可将自体细胞和基因治疗的成本降低30-50%。人工智慧与自动化的协同作用加速了细胞和基因治疗的发展，并确保了越来越多的慢性病患者能够平等地获得治疗。这使其成为细胞和基因治疗市场的重要趋势。

最终用户洞察

按最终用户划分，细胞和基因治疗市场可分为受託研究机构(CRO)、製药和生物製药公司以及学术和研究机构。截至 2024 年，製药和生物製药公司占据了最大的市场。成长推动要素包括医疗保健支出不断增加以及政府推出有利于临床试验的法规，这些因素对寻求多样化遗传背景以开发个人化医疗的跨国公司极具吸引力。遗传疾病的日益普遍和製造成本的下降正在刺激国内药品生产，从而促进从学名药向 CAR-T 疗法等先进治疗方法的过渡。自 2014 年以来，各国监管协调，例如日本引入再生医学有条件批准核准，降低了投资风险。在日本成功开发 CAR-T 疗法的主要企业包括Astellas製药和武田製药。这两家公司都透过对白血病患者的临床试验，在日本开发了 CAR-T 候选药物。日本也透过FUJIFILM细胞动力有限公司在iPS细胞技术的应用上主导。在中国，百济神州和传奇生物（与强生公司合作）已将BCMA标靶治疗商业化用于治疗多发性骨髓瘤，受益于上海庞大的患者群体和政府支持的丛集，推动了细胞和基因治疗市场的成长。

目录

第一章执行摘要

  • 分析师市场展望
  • 市场吸引力

第二章：细胞与基因治疗市场的市场状况

  • 价值链分析
  • 供应链分析
    • 製造商和供应商列表
    • 潜在客户名单（最多 50 家公司）
  • PEST分析
  • 人工智慧（AI）的影响
  • 细胞疗法或技术蓝图
  • 永续性与ESG趋势
  • 专利分析
  • 法律规范

第三章 竞争情势

  • 主要企业进行企业标竿分析
  • 2024年主要企业市占率分析
  • 市场集中度

第四章 细胞与基因治疗市场－主要市场动态

  • 市场驱动因素
    • 慢性病和遗传性疾病增多
    • 细胞和基因治疗製造外包业务快速成长
    • 监管核准和商业化激增
  • 市场限制
    • 开发和治疗高成本
    • 严峻的监理挑战
    • 缺乏技术熟练的专业人员和基础设施
  • 市场机会
    • 企业策略倡议
    • 政府支持措施
    • 增加对研发和临床试验的投入
  • 未来趋势
    • 人工智慧 (AI) 与自动化的融合
    • 下一代基因编辑工具的开发
    • 同种异体移植和现成疗法的兴起
  • 促进因素和抑制因素的影响

5. 细胞与基因治疗市场－全球市场分析

  • 细胞与基因疗法市场收入（2021-2031 年）
  • 细胞与基因治疗市场预测与分析

6. 细胞和基因治疗市场按类型分類的收入分析

  • 细胞与基因治疗市场预测与分析（按类型）
    • 细胞疗法
      • 细胞疗法：细胞和基因疗法市场—收入，2021-2031年
    • 基因治疗
      • 基因疗法：细胞和基因疗法市场—收入，2021-2031年

7. 细胞和基因治疗市场按服务分類的收入分析

  • 细胞及基因治疗市场预测及服务分析
    • 製程开发
      • 製程开发：细胞与基因治疗市场－收入，2021-2031年
    • cGMP生产
      • cGMP 生产：细胞和基因治疗市场 - 收入，2021-2031 年
    • 监管服务
      • 监管服务：细胞与基因治疗市场－收入，2021-2031年
    • 生物检测服务
      • 生物检测服务：细胞和基因治疗市场 - 收入，2021-2031 年

8. 细胞和基因治疗市场规模收入分析

  • 细胞与基因治疗市场规模预测与分析
    • 商业化前/研发/生产
      • 商业化前/研发生产：细胞与基因治疗市场－收入，2021-2031年
    • 商业规模生产
      • 商业化规模生产：细胞与基因治疗市场－收入，2021-2031年

9. 细胞和基因治疗市场按服务供应商的收入分析

  • 细胞和基因治疗市场预测及服务供应商分析
    • CDMO
      • CDMO：细胞和基因治疗市场－收入，2021-2031年
    • CMO
      • CMO：细胞与基因治疗市场－收入，2021-2031年

10. 细胞与基因治疗市场收入分析－转染试剂

  • 细胞与基因治疗市场预测与分析（按转染试剂划分）
    • 以聚合物为基础的转染试剂
      • 聚合物为基础的转染试剂：细胞和基因治疗市场－收入，2021-2031年
    • 基于脂质的转染试剂
      • 以脂质为基础的转染试剂：细胞与基因治疗市场－收入，2021-2031年
    • 病毒转导增强子
      • 病毒转导增强剂：细胞和基因治疗市场－收入，2021-2031年
    • 其他转染试剂
      • 其他转染试剂：细胞和基因治疗市场－收入，2021-2031年

第十一章 细胞和基因治疗市场按最终用户分類的收入分析

  • 细胞及基因治疗市场预测及最终用户分析
  • 学术和研究机构

第十二章：细胞与基因治疗市场－区域分析

  • 北美洲
    • 按类型
    • 按类型分類的细胞疗法
    • 依基因治疗类型
    • 服务
    • 规模
    • 服务提供者
    • 转染试剂
    • 最终用户
    • 美国市场
    • 加拿大市场
    • 墨西哥市场
  • 欧洲
    • 英国市场
    • 德国市场
    • 法国市场
    • 义大利市场
    • 西班牙市场
    • 其他欧洲市场
  • 亚太地区
    • 中国市场
    • 日本市场
    • 印度市场
    • 澳洲市场
    • 韩国市场
    • 亚太地区的其他国家
  • 中东和非洲市场
    • 沙乌地阿拉伯市场
    • 南非市场
    • 阿联酋市场
    • 其他中东和非洲市场
  • 南美洲和中美洲
    • 南美洲和拉丁美洲市场
      • 巴西市场
      • 阿根廷市场
      • 其他南美洲和中美洲及其他区域市场

第十三章 细胞与基因治疗市场产业概况

第十四章 细胞与基因治疗市场－主要企业概况

  • CRISPR Therapeutics
  • Horizon Discovery Group plc.
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Integrated DNA Technologies Inc.
  • QIAGEN NV
  • Takara Bio Inc
  • Synthego Holdings LLC
  • GenScript Biotech Corporation
  • Editas Medicine Inc

第十五章附录

Product Code: TIPRE00020854

The cell and gene therapy market size is expected to grow from US$ 5.30 billion in 2024 to US$ 25.78 billion by 2031; it is projected to register a CAGR of 25.5% during 2025-2031. The increasing prevalence of chronic and genetic diseases, the rapid popularity of outsourcing cell and gene therapy manufacturing, and surging regulatory approvals and commercialization are noteworthy factors contributing to the expansion of the cell and gene therapy market size. Additionally, the development of next-generation gene editing tools is projected to bring new cell and gene therapy market trends in the near future.

AI and automation are making a revolutionary impact in the realm of CGT. This academic field has been using AI for predictive modeling, in association with automated process improvement for planning, to overcome current challenges. CRISPR-GPT at Stanford Medicine, an AI technology capable of automating the planning of experiments related to editing genes, has reduced the "time burden of trial-and-error" phases from months to mere days. Similarly, the Yale School of Medicine's generative AI model designs "new DNA sequences" to switch genes "on" and "off" for the development of safer "gene therapy vectors" in preclinical studies.

Automation works well with AI as it reduces human involvement in the manufacturing process. In this regard, the Cell Shuttle system by Cellares relies on robotics for completeCAR-T cell manufacturing with higher purity and an increased processing speed of up to 10 times. These developments provide significant benefits. According to BioProcess International, automation can reduce autologous CGT cost by 30-50% through enhanced compliance and flexibility. The synergy between AI and automation fast-tracks CGT, which ensures equal treatment access for those affected by rising chronic diseases, thereby emerging as a significant trend in the cell and gene therapy market.

End User-Based Insights

Based on end user, the cell and gene therapy market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest cell and gene therapy market share in 2024. The driving forces of growth include increasing expenditures in the healthcare sector and favorable government regulations, which accelerate clinical trials; these offer attractions to MNCs looking for varying genetic backgrounds for the development of personalized medications. The growing number of genetic ailments as well as fewer costs of manufacturing act as stimuli for the domestic manufacturing of medications, thus facilitating a transition from generics to more advanced therapies like CAR-T. Improved regulatory harmonization among the countries, with Japan introducing conditional approval of regenerative therapies since 2014, reduces the risks associated with investment. Key players who have successfully developed CAR-T therapies in Japan include the country's own Astellas Pharma and Takeda Pharmaceutical companies, who have developed CAR-T candidates in Japan through clinical trials in patients with leukemia. Japan has the lead in adopting iPS cell technology through the Fujifilm Cellular Dynamics company. In China, Beigene and Legend Biotech (in collaboration with Johnson & Johnson) have commercialized BCMA-targeted therapies for multiple myeloma, benefiting from massive patient pools and government-backed bioclusters in Shanghai, thereby fueling the cell and gene therapy market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the cell and gene therapy market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Cell and Gene Therapy Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 PEST Analysis
  • 2.5 Impact of Artificial Intelligence (AI)
  • 2.6 Cell Therapy or Technology Roadmap
  • 2.7 Sustainability and ESG Trends
  • 2.8 Patent Analysis
  • 2.9 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2024 - By Key Players
  • 3.3 Market Concentration

4. Cell and Gene Therapy Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Genetic Diseases
    • 4.1.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surging Regulatory Approvals and Commercialization
  • 4.2 Market Restraints
    • 4.2.1 High Costs of Development and Treatment
    • 4.2.2 Stringent Regulatory Challenges
    • 4.2.3 Shortage Of Skilled Professionals and Infrastructure
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Companies
    • 4.3.2 Supportive Government Initiatives
    • 4.3.3 Rising Investments in Research & Development and Clinical Trials
  • 4.4 Future Trends
    • 4.4.1 Integration of AI and Automation
    • 4.4.2 Development of Next-Generation Gene Editing Tools
    • 4.4.3 Rise of Allogeneic and Off-The-Shelf Therapies
  • 4.5 Impact of Drivers and Restraints

5. Cell and Gene Therapy Market - Global Market Analysis

  • 5.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • 5.2 Cell and Gene Therapy Market Forecast and Analysis

6. Cell and Gene Therapy Market Revenue Analysis -Type

  • 6.1 Cell and Gene Therapy Market Forecasts and Analysis by Type
    • 6.1.1 Cell Therapy
      • 6.1.1.1 Overview
      • 6.1.1.2 Cell Therapy: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 6.1.2 Gene Therapy
      • 6.1.2.1 Overview
      • 6.1.2.2 Gene Therapy: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

7. Cell and Gene Therapy Market Revenue Analysis -Service

  • 7.1 Cell and Gene Therapy Market Forecasts and Analysis by Service
    • 7.1.1 Process Development
      • 7.1.1.1 Overview
      • 7.1.1.2 Process Development: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.2 cGMP Manufacturing
      • 7.1.2.1 Overview
      • 7.1.2.2 cGMP Manufacturing: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.3 Regulatory Services
      • 7.1.3.1 Overview
      • 7.1.3.2 Regulatory Services: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.4 Bioassay Services
      • 7.1.4.1 Overview
      • 7.1.4.2 Bioassay Services: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

8. Cell and Gene Therapy Market Revenue Analysis - Scale

  • 8.1 Cell and Gene Therapy Market Forecasts and Analysis by Scale
    • 8.1.1 Pre-commercial/R and D Manufacturing
      • 8.1.1.1 Overview
      • 8.1.1.2 Pre-commercial/R and D Manufacturing: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 8.1.2 Commercial Scale Manufacturing
      • 8.1.2.1 Overview
      • 8.1.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

9. Cell and Gene Therapy Market Revenue Analysis -Service Providers

  • 9.1 Cell and Gene Therapy Market Forecasts and Analysis by Service Providers
    • 9.1.1 CDMOs
      • 9.1.1.1 Overview
      • 9.1.1.2 CDMOs: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.2 CMOs
      • 9.1.2.1 Overview
      • 9.1.2.2 CMOs: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

10. Cell and Gene Therapy Market Revenue Analysis - Transfection Reagents

  • 10.1 Cell and Gene Therapy Market Forecasts and Analysis by Transfection Reagents
    • 10.1.1 Polymer-based Transfection Reagents
      • 10.1.1.1 Overview
      • 10.1.1.2 Polymer-based Transfection Reagents: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.2 Lipid-based Transfection Reagents
      • 10.1.2.1 Overview
      • 10.1.2.2 Lipid-based Transfection Reagents: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.3 Viral Transduction Enhancers
      • 10.1.3.1 Overview
      • 10.1.3.2 Viral Transduction Enhancers: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.4 Other Transfection Reagents
      • 10.1.4.1 Overview
      • 10.1.4.2 Other Transfection Reagents: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

11. Cell and Gene Therapy Market Revenue Analysis - By End User

  • 11.1 Cell and Gene Therapy Market Forecasts and Analysis by End User
    • 11.1.1 Contract Research Organizations
      • 11.1.1.1 Overview
      • 11.1.1.2 Contract Research Organizations: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 11.1.2 Pharmaceutical and Biopharmaceutical Companies
      • 11.1.2.1 Overview
      • 11.1.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
  • 11.1. Academic and Research Institutes
      • 11.1.3.1 Overview
      • 11.1.3.2 Academic and Research Institutes: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

12. Cell and Gene Therapy Market - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Cell and Gene Therapy Market Overview
    • 12.1.2 North America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.1.3 North America: Cell and Gene Therapy Market- By Segmentation
      • 12.1.3.1 Type
      • 12.1.3.2 Cell Therapy For Type
      • 12.1.3.3 Gene Therapy For Type
      • 12.1.3.4 Service
      • 12.1.3.5 Scale
      • 12.1.3.6 Service Providers
      • 12.1.3.7 Transfection Reagents
      • 12.1.3.8 End User
    • 12.1.4 North America: Cell and Gene Therapy Market Breakdown by Countries
      • 12.1.4.1 United States Market
        • 12.1.4.1.1 United States: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.1.4.1.2 United States: Cell and Gene Therapy Market- By Segmentation
          • 12.1.4.1.2.1 Type
          • 12.1.4.1.2.2 Cell Therapy For Type
          • 12.1.4.1.2.3 Gene Therapy For Type
          • 12.1.4.1.2.4 Service
          • 12.1.4.1.2.5 Scale
          • 12.1.4.1.2.6 Service Providers
          • 12.1.4.1.2.7 Transfection Reagents
          • 12.1.4.1.2.8 End User
      • 12.1.4.2 Canada Market
        • 12.1.4.2.1 Canada: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.1.4.2.2 Canada: Cell and Gene Therapy Market- By Segmentation
          • 12.1.4.2.2.1 Type
          • 12.1.4.2.2.2 Cell Therapy For Type
          • 12.1.4.2.2.3 Gene Therapy For Type
          • 12.1.4.2.2.4 Service
          • 12.1.4.2.2.5 Scale
          • 12.1.4.2.2.6 Service Providers
          • 12.1.4.2.2.7 Transfection Reagents
          • 12.1.4.2.2.8 End User
      • 12.1.4.3 Mexico Market
        • 12.1.4.3.1 Mexico: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.1.4.3.2 Mexico: Cell and Gene Therapy Market- By Segmentation
          • 12.1.4.3.2.1 Type
          • 12.1.4.3.2.2 Cell Therapy For Type
          • 12.1.4.3.2.3 Gene Therapy For Type
          • 12.1.4.3.2.4 Service
          • 12.1.4.3.2.5 Scale
          • 12.1.4.3.2.6 Service Providers
          • 12.1.4.3.2.7 Transfection Reagents
          • 12.1.4.3.2.8 End User
  • 12.2 Europe
    • 12.2.1 Europe Cell and Gene Therapy Market Overview
    • 12.2.2 Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.2.3 Europe: Cell and Gene Therapy Market- By Segmentation
      • 12.2.3.1 Type
      • 12.2.3.2 Cell Therapy For Type
      • 12.2.3.3 Gene Therapy For Type
      • 12.2.3.4 Service
      • 12.2.3.5 Scale
      • 12.2.3.6 Service Providers
      • 12.2.3.7 Transfection Reagents
      • 12.2.3.8 End User
    • 12.2.4 Europe: Cell and Gene Therapy Market Breakdown by Countries
      • 12.2.4.1 United Kingdom Market
        • 12.2.4.1.1 United Kingdom: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.1.2 United Kingdom: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.1.2.1 Type
          • 12.2.4.1.2.2 Cell Therapy For Type
          • 12.2.4.1.2.3 Gene Therapy For Type
          • 12.2.4.1.2.4 Service
          • 12.2.4.1.2.5 Scale
          • 12.2.4.1.2.6 Service Providers
          • 12.2.4.1.2.7 Transfection Reagents
          • 12.2.4.1.2.8 End User
      • 12.2.4.2 Germany Market
        • 12.2.4.2.1 Germany: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.2.2 Germany: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.2.2.1 Type
          • 12.2.4.2.2.2 Cell Therapy For Type
          • 12.2.4.2.2.3 Gene Therapy For Type
          • 12.2.4.2.2.4 Service
          • 12.2.4.2.2.5 Scale
          • 12.2.4.2.2.6 Service Providers
          • 12.2.4.2.2.7 Transfection Reagents
          • 12.2.4.2.2.8 End User
      • 12.2.4.3 France Market
        • 12.2.4.3.1 France: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.3.2 France: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.3.2.1 Type
          • 12.2.4.3.2.2 Cell Therapy For Type
          • 12.2.4.3.2.3 Gene Therapy For Type
          • 12.2.4.3.2.4 Service
          • 12.2.4.3.2.5 Scale
          • 12.2.4.3.2.6 Service Providers
          • 12.2.4.3.2.7 Transfection Reagents
          • 12.2.4.3.2.8 End User
      • 12.2.4.4 Italy Market
        • 12.2.4.4.1 Italy: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.4.2 Italy: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.4.2.1 Type
          • 12.2.4.4.2.2 Cell Therapy For Type
          • 12.2.4.4.2.3 Gene Therapy For Type
          • 12.2.4.4.2.4 Service
          • 12.2.4.4.2.5 Scale
          • 12.2.4.4.2.6 Service Providers
          • 12.2.4.4.2.7 Transfection Reagents
          • 12.2.4.4.2.8 End User
      • 12.2.4.5 Spain Market
        • 12.2.4.5.1 Spain: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.5.2 Spain: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.5.2.1 Type
          • 12.2.4.5.2.2 Cell Therapy For Type
          • 12.2.4.5.2.3 Gene Therapy For Type
          • 12.2.4.5.2.4 Service
          • 12.2.4.5.2.5 Scale
          • 12.2.4.5.2.6 Service Providers
          • 12.2.4.5.2.7 Transfection Reagents
          • 12.2.4.5.2.8 End User
      • 12.2.4.6 Rest of Europe Market
        • 12.2.4.6.1 Rest of Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.6.2 Rest of Europe: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.6.2.1 Type
          • 12.2.4.6.2.2 Cell Therapy For Type
          • 12.2.4.6.2.3 Gene Therapy For Type
          • 12.2.4.6.2.4 Service
          • 12.2.4.6.2.5 Scale
          • 12.2.4.6.2.6 Service Providers
          • 12.2.4.6.2.7 Transfection Reagents
          • 12.2.4.6.2.8 End User
  • 12.3 Asia Pacific
    • 12.3.1 Asia Pacific Cell and Gene Therapy Market Overview
    • 12.3.2 Asia Pacific: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.3.3 Asia Pacific: Cell and Gene Therapy Market- By Segmentation
      • 12.3.3.1 Type
      • 12.3.3.2 Cell Therapy For Type
      • 12.3.3.3 Gene Therapy For Type
      • 12.3.3.4 Service
      • 12.3.3.5 Scale
      • 12.3.3.6 Service Providers
      • 12.3.3.7 Transfection Reagents
      • 12.3.3.8 End User
    • 12.3.4 Asia Pacific: Cell and Gene Therapy Market Breakdown by Countries
      • 12.3.4.1 China Market
        • 12.3.4.1.1 China: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.1.2 China: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.1.2.1 Type
          • 12.3.4.1.2.2 Cell Therapy For Type
          • 12.3.4.1.2.3 Gene Therapy For Type
          • 12.3.4.1.2.4 Service
          • 12.3.4.1.2.5 Scale
          • 12.3.4.1.2.6 Service Providers
          • 12.3.4.1.2.7 Transfection Reagents
          • 12.3.4.1.2.8 End User
      • 12.3.4.2 Japan Market
        • 12.3.4.2.1 Japan: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.2.2 Japan: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.2.2.1 Type
          • 12.3.4.2.2.2 Cell Therapy For Type
          • 12.3.4.2.2.3 Gene Therapy For Type
          • 12.3.4.2.2.4 Service
          • 12.3.4.2.2.5 Scale
          • 12.3.4.2.2.6 Service Providers
          • 12.3.4.2.2.7 Transfection Reagents
          • 12.3.4.2.2.8 End User
      • 12.3.4.3 India Market
        • 12.3.4.3.1 India: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.3.2 India: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.3.2.1 Type
          • 12.3.4.3.2.2 Cell Therapy For Type
          • 12.3.4.3.2.3 Gene Therapy For Type
          • 12.3.4.3.2.4 Service
          • 12.3.4.3.2.5 Scale
          • 12.3.4.3.2.6 Service Providers
          • 12.3.4.3.2.7 Transfection Reagents
          • 12.3.4.3.2.8 End User
      • 12.3.4.4 Australia Market
        • 12.3.4.4.1 Australia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.4.2 Australia: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.4.2.1 Type
          • 12.3.4.4.2.2 Cell Therapy For Type
          • 12.3.4.4.2.3 Gene Therapy For Type
          • 12.3.4.4.2.4 Service
          • 12.3.4.4.2.5 Scale
          • 12.3.4.4.2.6 Service Providers
          • 12.3.4.4.2.7 Transfection Reagents
          • 12.3.4.4.2.8 End User
      • 12.3.4.5 South Korea Market
        • 12.3.4.5.1 South Korea: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.5.2 South Korea: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.5.2.1 Type
          • 12.3.4.5.2.2 Cell Therapy For Type
          • 12.3.4.5.2.3 Gene Therapy For Type
          • 12.3.4.5.2.4 Service
          • 12.3.4.5.2.5 Scale
          • 12.3.4.5.2.6 Service Providers
          • 12.3.4.5.2.7 Transfection Reagents
          • 12.3.4.5.2.8 End User
      • 12.3.4.6 Rest of APAC Market
        • 12.3.4.6.1 Rest of APAC: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.6.2 Rest of APAC: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.6.2.1 Type
          • 12.3.4.6.2.2 Cell Therapy For Type
          • 12.3.4.6.2.3 Gene Therapy For Type
          • 12.3.4.6.2.4 Service
          • 12.3.4.6.2.5 Scale
          • 12.3.4.6.2.6 Service Providers
          • 12.3.4.6.2.7 Transfection Reagents
          • 12.3.4.6.2.8 End User
  • 12.4 Middle East and Africa
    • 12.4.1 Middle East and Africa Cell and Gene Therapy Market Overview
    • 12.4.2 Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.4.3 Middle East and Africa: Cell and Gene Therapy Market- By Segmentation
      • 12.4.3.1 Type
      • 12.4.3.2 Cell Therapy For Type
      • 12.4.3.3 Gene Therapy For Type
      • 12.4.3.4 Service
      • 12.4.3.5 Scale
      • 12.4.3.6 Service Providers
      • 12.4.3.7 Transfection Reagents
      • 12.4.3.8 End User
    • 12.4.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown by Countries
      • 12.4.4.1 Saudi Arabia Market
        • 12.4.4.1.1 Saudi Arabia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.1.2 Saudi Arabia: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.1.2.1 Type
          • 12.4.4.1.2.2 Cell Therapy For Type
          • 12.4.4.1.2.3 Gene Therapy For Type
          • 12.4.4.1.2.4 Service
          • 12.4.4.1.2.5 Scale
          • 12.4.4.1.2.6 Service Providers
          • 12.4.4.1.2.7 Transfection Reagents
          • 12.4.4.1.2.8 End User
      • 12.4.4.2 South Africa Market
        • 12.4.4.2.1 South Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.2.2 South Africa: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.2.2.1 Type
          • 12.4.4.2.2.2 Cell Therapy For Type
          • 12.4.4.2.2.3 Gene Therapy For Type
          • 12.4.4.2.2.4 Service
          • 12.4.4.2.2.5 Scale
          • 12.4.4.2.2.6 Service Providers
          • 12.4.4.2.2.7 Transfection Reagents
          • 12.4.4.2.2.8 End User
      • 12.4.4.3 United Arab Emirates Market
        • 12.4.4.3.1 United Arab Emirates: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.3.2 United Arab Emirates: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.3.2.1 Type
          • 12.4.4.3.2.2 Cell Therapy For Type
          • 12.4.4.3.2.3 Gene Therapy For Type
          • 12.4.4.3.2.4 Service
          • 12.4.4.3.2.5 Scale
          • 12.4.4.3.2.6 Service Providers
          • 12.4.4.3.2.7 Transfection Reagents
          • 12.4.4.3.2.8 End User
      • 12.4.4.4 Rest of Middle East and Africa Market
        • 12.4.4.4.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.4.2 Rest of Middle East and Africa: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.4.2.1 Type
          • 12.4.4.4.2.2 Cell Therapy For Type
          • 12.4.4.4.2.3 Gene Therapy For Type
          • 12.4.4.4.2.4 Service
          • 12.4.4.4.2.5 Scale
          • 12.4.4.4.2.6 Service Providers
          • 12.4.4.4.2.7 Transfection Reagents
          • 12.4.4.4.2.8 End User
  • 12.5 South and Central America
    • 12.5.1 South and Central America Cell and Gene Therapy Market Overview
    • 12.5.2 South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.5.3 South and Central America: Cell and Gene Therapy Market- By Segmentation
      • 12.5.3.1 Type
      • 12.5.3.2 Cell Therapy For Type
      • 12.5.3.3 Gene Therapy For Type
      • 12.5.3.4 Service
      • 12.5.3.5 Scale
      • 12.5.3.6 Service Providers
      • 12.5.3.7 Transfection Reagents
      • 12.5.3.8 End User
    • 12.5.4 South and Central America: Cell and Gene Therapy Market Breakdown by Countries
      • 12.5.4.1 Brazil Market
        • 12.5.4.1.1 Brazil: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.5.4.1.2 Brazil: Cell and Gene Therapy Market- By Segmentation
          • 12.5.4.1.2.1 Type
          • 12.5.4.1.2.2 Cell Therapy For Type
          • 12.5.4.1.2.3 Gene Therapy For Type
          • 12.5.4.1.2.4 Service
          • 12.5.4.1.2.5 Scale
          • 12.5.4.1.2.6 Service Providers
          • 12.5.4.1.2.7 Transfection Reagents
          • 12.5.4.1.2.8 End User
      • 12.5.4.2 Argentina Market
        • 12.5.4.2.1 Argentina: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.5.4.2.2 Argentina: Cell and Gene Therapy Market- By Segmentation
          • 12.5.4.2.2.1 Type
          • 12.5.4.2.2.2 Cell Therapy For Type
          • 12.5.4.2.2.3 Gene Therapy For Type
          • 12.5.4.2.2.4 Service
          • 12.5.4.2.2.5 Scale
          • 12.5.4.2.2.6 Service Providers
          • 12.5.4.2.2.7 Transfection Reagents
          • 12.5.4.2.2.8 End User
      • 12.5.4.3 Rest of South and Central America Market
        • 12.5.4.3.1 Rest of South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.5.4.3.2 Rest of South and Central America: Cell and Gene Therapy Market- By Segmentation
          • 12.5.4.3.2.1 Type
          • 12.5.4.3.2.2 Cell Therapy For Type
          • 12.5.4.3.2.3 Gene Therapy For Type
          • 12.5.4.3.2.4 Service
          • 12.5.4.3.2.5 Scale
          • 12.5.4.3.2.6 Service Providers
          • 12.5.4.3.2.7 Transfection Reagents
          • 12.5.4.3.2.8 End User

13. Cell and Gene Therapy Market Industry Landscape

14. Cell and Gene Therapy Market - Key Company Profiles

  • 14.1 CRISPR Therapeutics
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Cell Therapys and Gene Therapy
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Horizon Discovery Group plc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Cell Therapys and Gene Therapy
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Cell Therapys and Gene Therapy
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Merck KGaA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Cell Therapys and Gene Therapy
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Integrated DNA Technologies Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Cell Therapys and Gene Therapy
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 QIAGEN NV
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Cell Therapys and Gene Therapy
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Takara Bio Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Cell Therapys and Gene Therapy
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Synthego Holdings LLC
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Cell Therapys and Gene Therapy
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GenScript Biotech Corporation
    • 14.9.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Cell Therapys and Gene Therapy
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Editas Medicine Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Cell Therapys and Gene Therapy
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary
  • 15.2 Research Methodology and Approach
    • 15.2.1 Secondary Research
    • 15.2.2 Primary Research
    • 15.2.3 Market Estimation Approach
      • 15.2.3.1 Supply Side Analysis
      • 15.2.3.2 Demand Side Analysis
    • 15.2.4 Research Assumptions and Limitations
    • 15.2.5 Currency Conversion
  • 15.3 About The Insight Partners
  • 15.4 Market Intelligence Cloud

List Of Tables

  • Table 1. Cell and Gene Therapy Market Segmentation
  • Table 2. List of Service Providers
  • Table 3. List of Potential Customers
  • Table 4. List of Patents and Description
  • Table 5. List of Regulatory Bodies and Organizations
  • Table 6. Ease of Doing Business: Key Country Rankings
  • Table 7. Market Share Analysis, 2024 - By Key Players
  • Table 8. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million)
  • Table 6. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million)
  • Table 7. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Type
  • Table 8. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Type
  • Table 9. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 10. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 11. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 12. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 13. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 14. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 15. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 16. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 17. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 18. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 19. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 20. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 21. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 22. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 23. North America: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 24. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 25. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 26. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 27. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 28. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 29. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 30. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 31. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 32. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 33. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 34. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 35. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 36. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 37. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 38. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 39. North America: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 40. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 41. United States: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 42. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 43. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 44. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 45. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 46. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 47. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 48. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 49. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 50. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 51. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 52. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 53. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 54. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 55. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 56. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 57. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 58. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 59. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 60. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 61. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 62. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 63. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 64. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 65. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 66. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 67. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 68. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 69. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 70. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 71. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 72. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 73. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 74. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 75. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 76. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 77. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 78. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 79. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 80. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 81. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 82. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 83. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 84. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 85. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 86. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 87. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 88. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 89. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 90. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 91. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 92. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 93. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 94. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 95. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 96. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 97. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 98. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 99. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 100. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 101. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 102. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 103. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 104. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 105. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 106. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 107. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 108. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 109. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 110. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 111. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 112. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 113. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 114. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 115. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 116. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 117. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 118. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 119. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 120. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 121. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 122. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 123. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 124. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 125. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 126. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 127. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 128. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 129. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 130. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 131. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 132. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 133. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 134. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 135. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 136. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 137. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 138. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 139. France: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 140. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 141. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 142. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 143. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 144. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 145. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 146. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 147. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 148. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 149. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 150. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 151. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 152. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 153. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 154. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 155. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 156. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 157. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 158. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 159. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 160. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 161. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 162. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 163. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 164. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 165. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 166. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 167. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 168. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 169. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 170. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 171. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 172. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 173. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 174. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 175. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 176. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 177. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 178. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 179. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 180. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 181. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 182. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 183. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 184. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 185. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 186. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 187. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 188. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 189. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 190. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 191. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 192. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 193. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 194. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 195. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 196. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 197. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 198. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 199. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 200. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 201. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 202. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 203. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 204. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 205. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 206. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 207. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 208. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 209. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 210. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 211. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 212. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 213. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 214. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 215. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 216. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 217. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 218. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 219. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 220. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 221. China: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 222. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 223. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 224. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 225. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 226. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 227. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 228. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 229. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 230. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 231. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 232. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 233. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 234. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 235. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 236. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 237. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 238. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 239. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 240. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 241. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 242. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 243. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 244. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 245. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 246. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 247. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 248. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 249. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 250. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 251. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 252. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 253. India: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 254. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 255. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 256. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 257. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 258. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 259. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 260. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 261. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 262. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 263. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 264. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 265. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 266. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 267. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 268. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 269. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 270. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 271. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 272. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 273. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 274. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 275. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 276. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 277. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 278. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 279. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 280. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 281. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 282. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 283. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 284. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 285. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 286. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 287. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 288. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 289. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 290. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 291. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 292. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 293. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 294. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 295. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 296. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 297. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 298. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 299. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 300. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 301. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 302. Rest of APAC: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 303. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 304. Rest of APAC: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 305. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 306. Rest of APAC: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 307. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 308. Rest of APAC: Cell and Gene T

List Of Figures

  • Figure 1. Cell and Gene Therapy Market - Value Chain Analysis
  • Figure 2. Pest Analysis
  • Figure 3. Cell and Gene Therapy Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • Figure 6. Cell and Gene Therapy Market Share (%) - by Type (2024 and 2031)
  • Figure 7. Cell Therapy: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 8. Gene Therapy: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 9. Cell and Gene Therapy Market Share (%) - by Service (2024 and 2031)
  • Figure 10. Process Development: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 11. cGMP Manufacturing: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 12. Regulatory Services: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 13. Bioassay Services: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 14. Cell and Gene Therapy Market Share (%) - by Scale (2024 and 2031)
  • Figure 15. Pre-commercial/R and D Manufacturing: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 16. Commercial Scale Manufacturing: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 17. Cell and Gene Therapy Market Share (%) - by Service Providers (2024 and 2031)
  • Figure 18. CDMOs: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 19. CMOs: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 20. Cell and Gene Therapy Market Share (%) - by Transfection Reagents (2024 and 2031)
  • Figure 21. Polymer-based Transfection Reagents: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 22. Lipid-based Transfection Reagents: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 23. Viral Transduction Enhancers: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 24. Other Transfection Reagents: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 25. Cell and Gene Therapy Market Share (%) - by End User (2024 and 2031)
  • Figure 26. Contract Research Organizations: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 27. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 28. Academic and Research Institutes: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 29. Cell and Gene Therapy Market Breakdown by Geography, 2024 and 2031
  • Figure 30. North America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 31. North America: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 32. United States: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 33. Canada: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 34. Mexico: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 35. Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 36. Europe: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 37. United Kingdom: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 38. Germany: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 39. France: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 40. Italy: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 41. Spain: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 42. Rest of Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 43. Asia Pacific: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 44. Asia Pacific: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 45. China: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 46. Japan: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 47. India: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 48. Australia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 49. South Korea: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 50. Rest of APAC: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 51. Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 52. Middle East and Africa: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 53. Saudi Arabia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 54. South Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 55. United Arab Emirates: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 56. Rest of Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 58. South and Central America: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 59. Brazil: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 60. Argentina: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 61. Rest of South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 62. Bottom-Up Approach and Top-Down Approach